Literature DB >> 18827796

Vitamin D in chronic kidney disease: is the jury in?

Ian H de Boer1, Bryan Kestenbaum.   

Abstract

Vitamin D shows promise for improving diverse health outcomes among patients with chronic kidney disease. Observational studies of vitamin D medications have contributed important evidence for broad beneficial clinical effects of vitamin D beyond actions on bone. However, such studies are limited by the potential for confounding by indication. A large randomized controlled trial is now needed to test the hypothesis that vitamin D therapy improves clinical outcomes in patients with kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827796      PMCID: PMC3046549          DOI: 10.1038/ki.2008.419

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  In defense of pharmacoepidemiology--embracing the yin and yang of drug research.

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

2.  Association of activated vitamin D treatment and mortality in chronic kidney disease.

Authors:  Csaba P Kovesdy; Shahram Ahmadzadeh; John E Anderson; Kamyar Kalantar-Zadeh
Journal:  Arch Intern Med       Date:  2008-02-25

3.  Oral active vitamin D is associated with improved survival in hemodialysis patients.

Authors:  Manuel Naves-Díaz; Daniel Alvarez-Hernández; Jutta Passlick-Deetjen; Adrian Guinsburg; Cristina Marelli; Diego Rodriguez-Puyol; Jorge B Cannata-Andía
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

4.  Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

Authors:  M L Melamed; J A Eustace; L Plantinga; B G Jaar; N E Fink; J Coresh; M J Klag; N R Powe
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

5.  Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

Authors:  Ming Teng; Myles Wolf; M Norma Ofsthun; J Michael Lazarus; Miguel A Hernán; Carlos A Camargo; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

Review 6.  Impact of kidney bone disease and its management on survival of patients on dialysis.

Authors:  Grace H Lee; Deborah Benner; Deborah L Regidor; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2007-01       Impact factor: 3.655

7.  Mortality risk among hemodialysis patients receiving different vitamin D analogs.

Authors:  F Tentori; W C Hunt; C A Stidley; M R Rohrscheib; E J Bedrick; K B Meyer; H K Johnson; P G Zager
Journal:  Kidney Int       Date:  2006-10-04       Impact factor: 10.612

Review 8.  Vitamin D.

Authors:  Adriana S Dusso; Alex J Brown; Eduardo Slatopolsky
Journal:  Am J Physiol Renal Physiol       Date:  2005-07

9.  Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.

Authors:  Glenn M Chertow; Lara B Pupim; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drueke; Jürgen Floege; William G Goodman; Gerard M London; Kenneth W Mahaffey; Sharon M Moe; David C Wheeler; Moetaz Albizem; Kurt Olson; Preston Klassen; Patrick Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

10.  Association of oral calcitriol with improved survival in nondialyzed CKD.

Authors:  Abigail B Shoben; Kyle D Rudser; Ian H de Boer; Bessie Young; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2008-05-07       Impact factor: 10.121

  10 in total
  5 in total

1.  Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate.

Authors:  Ian H de Boer; Ronit Katz; Michel Chonchol; Joachim H Ix; Mark J Sarnak; Michael G Shlipak; David S Siscovick; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

2.  Vitamin D deficiency: consequence or cause of CKD?

Authors:  Ian H de Boer; Ravi Thadhani
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 8.237

3.  Circulating vitamin D metabolites and kidney disease in type 1 diabetes.

Authors:  Ian H de Boer; Michael C Sachs; Patricia A Cleary; Andrew N Hoofnagle; John M Lachin; Mark E Molitch; Michael W Steffes; Wanjie Sun; Bernard Zinman; John D Brunzell
Journal:  J Clin Endocrinol Metab       Date:  2012-09-18       Impact factor: 5.958

Review 4.  Vitamin D and glucose metabolism in chronic kidney disease.

Authors:  Ian H de Boer
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-11       Impact factor: 2.894

5.  Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.

Authors:  Gavin Dreyer; Arthur T Tucker; Steven M Harwood; Rupert M Pearse; Martin J Raftery; Muhammad M Yaqoob
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.